NasdaqGM - Delayed Quote USD

Fidelity Disruptive Medicine ETF (FMED)

23.95 +0.12 (+0.51%)
At close: April 26 at 4:00 PM EDT
Key Events
Loading Chart for FMED
DELL
  • Previous Close 23.83
  • Open 23.82
  • Bid --
  • Ask 23.97 x 100
  • Day's Range 23.82 - 23.99
  • 52 Week Range 19.88 - 25.73
  • Volume 7,557
  • Avg. Volume 5,865
  • Net Assets 54.04M
  • NAV 23.93
  • PE Ratio (TTM) --
  • Yield 0.00%
  • YTD Daily Total Return -1.12%
  • Beta (5Y Monthly) 0.98
  • Expense Ratio (net) 0.50%

The fund normally invests at least 80% of assets in securities of disruptive medicine companies. Fidelity's disruptive strategies seek to identify innovative developments that could signal new directions for delivering products and services to customers. Generally, these companies have or are developing new or unconventional ways of doing business that could disrupt and displace incumbents over time. The fund is non-diversified.

Fidelity Investments

Fund Family

Health

Fund Category

54.04M

Net Assets

2020-04-16

Inception Date

Performance Overview: FMED

Trailing returns as of 4/26/2024. Category is Health.

YTD Return

FMED
1.12%
Category
6.33%
 

1-Year Return

FMED
3.19%
Category
11.04%
 

3-Year Return

FMED
6.87%
Category
0.38%
 

People Also Watch

Holdings: FMED

Top 9 Holdings (31.49% of Total Assets)

SymbolCompany% Assets
BSX
Boston Scientific Corporation 5.76%
UNH
UnitedHealth Group Incorporated 3.92%
CNC
Centene Corporation 3.53%
DHR
Danaher Corporation 3.46%
MASI
Masimo Corporation 3.43%
ISRG
Intuitive Surgical, Inc. 3.38%
RPRX
Royalty Pharma plc 2.83%
PEN
Penumbra, Inc. 2.60%
SYK
Stryker Corporation 2.59%

Sector Weightings

SectorFMED
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Related ETF News

Related Tickers